Cargando…

Epitranscriptic regulation of HRAS by N(6)-methyladenosine drives tumor progression

Overexpression of Ras, in addition to the oncogenic mutations, occurs in various human cancers. However, the mechanisms for epitranscriptic regulation of RAS in tumorigenesis remain unclear. Here, we report that the widespread N(6)-methyladenosine (m(6)A) modification of HRAS, but not KRAS and NRAS,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yongbo, Gu, Yinmin, Liu, Tihui, Zhang, Qingqing, Yang, Facai, Duan, Liqiang, Cheng, Shuwen, Zhu, Xiaofeng, Xi, Yibo, Chang, Xiaoli, Ye, Qinong, Gao, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083612/ https://www.ncbi.nlm.nih.gov/pubmed/36996116 http://dx.doi.org/10.1073/pnas.2302291120

Ejemplares similares

LCDR regulates the integrity of lysosomal membrane by hnRNP K–stabilized LAPTM5 transcript and promotes cell survival
por: Yang, Xiwang, et al.
Publicado: (2022)

Decoding the epitranscriptional landscape from native RNA sequences
por: Jenjaroenpun, Piroon, et al.
Publicado: (2020)

Analysis and verification of N(6)-methyladenosine-modified genes as novel biomarkers for clear cell renal cell carcinoma
por: Yang, Zhenyu, et al.
Publicado: (2021)

Post-Transcriptional Regulation of Viral RNA through Epitranscriptional Modification
por: Courtney, David G.
Publicado: (2021)

8-Oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification
por: Hahm, Ja Young, et al.
Publicado: (2022)

HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1
por: Han, Xiaoqi, et al.
Publicado: (2023)

Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice
por: Fan, Tingting, et al.
Publicado: (2017)

DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma
por: Zhu, Yumeng, et al.
Publicado: (2022)

Association Analysis between Body Mass Index and Genomic DNA Methylation across 15 Major Cancer Types
por: Gu, Yinmin, et al.
Publicado: (2018)

Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model
por: Nandi, Sayantan, et al.
Publicado: (2022)

Regulatory role of N(6)-methyladenosine in intramuscular fat deposition in chicken
por: Zhang, Tong, et al.
Publicado: (2023)

MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells
por: Riemondy, Kent, et al.
Publicado: (2015)

Argonaute 2 modulates EGFR–RAS signaling to promote mutant HRAS and NRAS-driven malignancies
por: Siebenaler, Ronald F, et al.
Publicado: (2022)

New archaeal methyltransferases forming 1-methyladenosine or 1-methyladenosine and 1-methylguanosine at position 9 of tRNA
por: Kempenaers, Morgane, et al.
Publicado: (2010)

The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells
por: Chen, Xinyuan, et al.
Publicado: (2023)

Mechanism of the Exchange Reaction in HRAS from Multiscale Modeling
por: Kapoor, Abhijeet, et al.
Publicado: (2014)

HRAS mutation prevalence and associated expression patterns in pheochromocytoma
por: Stenman, Adam, et al.
Publicado: (2016)

Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation
por: Martin, R.J., et al.
Publicado: (2017)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

Mutant HRAS as novel target for MEK and mTOR inhibitors
por: Kiessling, Michael K., et al.
Publicado: (2015)

MTH1 expression is required for effective transformation by oncogenic HRAS
por: Giribaldi, Maria G., et al.
Publicado: (2015)

The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma
por: Wan, Xiaohua, et al.
Publicado: (2017)

Analysis of FGFR3 and HRAS genes in patients with bladder cancer
por: Homami, Ameneh, et al.
Publicado: (2020)

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
por: Ho, Alan L., et al.
Publicado: (2021)

Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS
por: Chen, Yi-Ting, et al.
Publicado: (2020)

Regulatory role of RNA N(6)-methyladenosine modifications during skeletal muscle development
por: Yu, Baojun, et al.
Publicado: (2022)

Functional Implications of Active N(6)-Methyladenosine in Plants
por: Zheng, Hongxiang, et al.
Publicado: (2020)

MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma
por: Miller, Michael B., et al.
Publicado: (2016)

WDR76 mediates obesity and hepatic steatosis via HRas destabilization
por: Park, Jong-Chan, et al.
Publicado: (2019)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
por: Sasaki, Eiichi, et al.
Publicado: (2020)

Poor Prognosis of Pulmonary Adenosquamous Carcinoma with NRAS and HRAS Double Mutation
por: Zhao, Jidong, et al.
Publicado: (2021)

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
por: Bièche, Ivan, et al.
Publicado: (2021)

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
por: Odeniyide, Patience, et al.
Publicado: (2022)

HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors
por: Liverani, Chiara, et al.
Publicado: (2023)

The Potential Roles of RNA N6-Methyladenosine in Urological Tumors
por: Li, Yang, et al.
Publicado: (2020)

N6-Methyladenosine Modification and Its Regulation of Respiratory Viruses
por: Feng, Qianyu, et al.
Publicado: (2021)

The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
por: Shi, Yue, et al.
Publicado: (2021)

Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity
por: Smith, Alison E., et al.
Publicado: (2023)

N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism
por: Wang, Yanying, et al.
Publicado: (2021)

RNA N(6)-methyladenosine modulates endothelial atherogenic responses to disturbed flow in mice
por: Li, Bochuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vj3nhvlrthve7l1sjlltsdfj56